Abstract:Abstract Rabies is an ancient disease. Two centuries since Pasteur, fundamental progress occurred in virology, vaccinology, and diagnostics—and an understanding of pathobiology and epizootiology of rabies in testament to One Health—before common terminological coinage. Prevention, control, selective elimination, and even the unthinkable—occasional treatment—of this zoonosis dawned by the twenty-first century. However, in contrast to smallpox and rinderpest, eradication is a wishful misnomer applied to rabies, particularly post-COVID-19 pandemic. Reasons are minion. Polyhostality encompasses bats and mesocarnivores, but other mammals represent a diverse spectrum of potential hosts. While rabies virus is the classical member of the genus, other species of lyssaviruses also cause the disease. Some reservoirs remain cryptic. Although global, this viral encephalitis is untreatable and often ignored. As with other neglected diseases, laboratory-based surveillance falls short of the notifiable ideal, especially in lower- and middle-income countries. Calculation of actual burden defaults to a flux within broad health economic models. Competing priorities, lack of defined, long-term international donors, and shrinking local champions challenge human prophylaxis and mass dog vaccination toward targets of 2030 for even canine rabies impacts. For prevention, all licensed vaccines are delivered to the individual, whether parenteral or oral–essentially ‘one and done’. Exploiting mammalian social behaviors, future ‘spreadable vaccines’ might increase the proportion of immunized hosts per unit effort. However, the release of replication-competent, genetically modified organisms selectively engineered to spread intentionally throughout a population raises significant biological, ethical, and regulatory issues in need of broader, transdisciplinary discourse. How this rather curious idea will evolve toward actual unconventional prevention, control, or elimination in the near term remains debatable. In the interim, more precise terminology and realistic expectations serve as the norm for diverse, collective constituents to maintain progress in the field.

Rabia: actualización epidemiológica y abordaje pre y postexposición

Rabies – epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review

Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms

Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination

Rabies Vaccine for Prophylaxis and Treatment of Rabies: A Narrative Review

Rabies in a postpandemic world: resilient reservoirs, redoubtable riposte, recurrent roadblocks, and resolute recidivism

Modern biologics for rabies prophylaxis and the elimination of human cases mediated by dogs

Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain

Novel Approaches to the Prevention and Treatment of Rabies.

Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment

Rabies and rabies research: past, present and future

Research Development of Rabies

Ecological and Socioeconomic Factors in the Occurrence of Rabies: A Forgotten Scenario

Alarming Rise in Global Rabies Cases Calls for Urgent Attention: Current Vaccination Status and Suggested Key Countermeasures

Research Progress on Neutralizing Epitopes and Antibodies for the Rabies Virus

Update on lyssaviruses and rabies: will past progress play as prologue in the near term towards future elimination?

Defining New Pathways to Manage the Ongoing Emergence of Bat Rabies in Latin America

Rabies-related brain disorders: transmission dynamics and epidemic management via educational campaigns and application of nanotechnology

New developments in rabies vaccination

Advances on Rabies Vaccines

Cost-Effectiveness Analysis of Rabies Control Program, 2008–2017: A Systematic Review